Mari Tinholt
Oslo, 0450, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Functional and Regulatory Effects of Factor V Leiden and Factor V rs6028 in Breast Cancer.
Journal: Genes
Published: April 14, 2025
The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 23, 2023
Coagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 26, 2023
Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells.
Journal: Thrombosis and haemostasis
Published: November 26, 2021
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer.
Journal: Oncoimmunology
Published: January 18, 2021
Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells.
Journal: Scientific reports
Published: September 19, 2019
Transcription factor FOXP3: A repressor of the TFPI gene?
Journal: Journal of cellular biochemistry
Published: March 22, 2018
Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 04, 2018
A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7.
Journal: Thrombosis research
Published: March 17, 2017
Determinants of acquired activated protein C resistance and D-dimer in breast cancer.
Journal: Thrombosis research
Published: June 10, 2016
Polymorphisms of the coagulation system and risk of cancer.
Journal: Thrombosis research
Published: April 13, 2016
Last Updated: 09/26/2026